Pertussis (Deseret Biologicals, Inc)


Welcome to the PulseAid listing for the Pertussis drug offered from Deseret Biologicals, Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc
NON-PROPRIETARY NAME: Aconitum Napellus, Antimonium Tartaricum, Belladonna, Bryonia, Hyoscyamus Niger, Ipecacuanha, Lobelia Inflata
SUBSTANCE NAME: ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA WHOLE; BRYONIA ALBA ROOT; HYOSCYAMUS NIGER; IPECAC; LOBELIA INFLATA; LOBARIA PULMONARIA; WOOD CREOSOTE; PHOSPHORUS; SILICON DIOXIDE; H
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2012-12-19
END MARKETING DATE: 2018-10-22


Pertussis HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPertussis from Deseret Biologicals, Inc
LABELER NAME: Deseret Biologicals, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4; 4; 4; 4; 4; 4; 4; 5; 5; 8; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2012-12-19
END MARKETING DATE: 2018-10-22
PRODUCT ID: 43742-0203_bbea3f00-c346-4071-97a6-f2472a34171a
PRODUCT NDC: 43742-0203
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA WHOLE; BRYONIA ALBA ROOT; HYOSCYAMUS NIGER; IPECAC; LOBELIA INFLATA; LOBARIA PULMONARIA; WOOD CREOSOTE; PHOSPHORUS; SILICON DIOXIDE; H Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, IncPertussis